Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine – CNBC
A person walks next to the Google Cloud logo at the Mobile World Congress (MWC) in Barcelona, Spain February 27, 2023.
Nacho Doce | Reuters
Google Cloud on Tuesday launched two new AI-powered tools that aim to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine.
One tool, called the Target and Lead Identification Suite, is designed to help companies predict and understand the structure of proteins, a fundamental part of drug development. Another, the Multiomics Suite, will help researchers ingest, store, analyze and share mass amounts of genomic data.
The new developments mark Googles latest advancement in the red-hot AI arms race, where tech companies are competing to dominate a market that analysts believe could someday be worth trillions. The company has faced pressure to showcase its generative artificial intelligence technology since the public release of OpenAIs ChatGPT late last year.
Google announced its generative chatbot Bard in February. Shares of its parent company Alphabet rose 4.3% last week after Google unveiled several AI advancements at its annual developer conference.
The two new Google Cloud suites help address a long-standing issue in the biopharma industry: the lengthy and costly process of bringing a new medicine to the U.S. market.
Drug companies can invest anywhere from a few hundred million dollars to more than $2 billion to launch a single drug, according to a recent Deloitte report. Their efforts arent always successful. Medicines that reach clinical trials have a 16% chance of being approved in the U.S., another Deloitte report says.
That hefty cost and bleak success rate is accompanied by an extensive and tedious research process that typically lasts about 10 to 15 years.
The new suites will save companies a statistically significant amount of time and money throughout the drug development process, said Shweta Maniar, Google Clouds global director of life sciences strategy and solutions. Google did not provide CNBC with specific figures.
We're helping organizations get medicines to the right people faster, Maniar told CNBC in an interview. I am personally very excited, this is something that myself and the team have been working on for a few years now.
Both suites are widely available to customers starting Tuesday. Google said the cost will vary depending on the company. Several businesses, including Big Pharma's Pfizer and the biotech companies Cerevel Therapeutics and Colossal Biosciences, have already been using the products.
The Target and Lead Identification Suite aims to streamline the first key step of drug development, which is identifying a biological target that researchers can focus on and design a treatment around, according to Maniar.
A biological target is most commonly a protein, an essential building block of diseases and all other parts of life. Finding that target involves identifying the structure of a protein, which determines its function, or the role it plays in a disease.
If you can understand the role, the protein structure and role, now you can start developing drugs around that, Maniar said.
But that process is time-consuming and often unsuccessful.
Scientists can take around 12 months just to identify a biological target, according to a widely followed guidance manual for drugmakers posted in a database run by the federal National Library of Medicine.The two techniques researchers traditionally use to determine protein structures also have a high rate of failure, according to Maniar.
She also said its difficult for traditional technologies to increase or decrease the amount of work they do based on demand.
Google Clouds suite has a three-pronged approach for making that process more efficient.
The suite allows scientists to ingest, share and manage molecular data on a protein using Google Clouds Analytics Hub, a platform that lets users securely exchange data across organizations.
Researchers can then use that data to predict the structure of a protein with AlphaFold2, a machine learning model developed by a subsidiary of Google.
AlphaFold2 runs on Googles Vertex AI pipeline, a platform that allows researchers to build and deploy machine learning models faster.
In minutes, AlphaFold2 can predict the 3D structure of a protein with more accuracy than traditional technologies and at the scale researchers need. Predicting that structure is critical because it can help researchers understand a proteins function in a disease.
The final component of Google Clouds suite helps researchers identify how the proteins structure interacts with different molecules. A molecule can become the basis for a new drug if it changes that proteins function and ultimately demonstrates the ability to treat the disease.
Researchers can use Google Cloud's high-performance computing resources to find the most promising molecules that could lead to the development of a new drug, according to a press release on the new tools. Those services provide the infrastructure companies need to accelerate, automate and scale up their work.
Cerevel, which focuses on developing treatments for neuroscience diseases, typically has to screen a large library of 3 million different molecules to find one that will produce a positive effect against a disease, according to Chief Scientific Officer John Renger. He called that process "complicated and involved and expensive."
But Renger said the company will be able to weed out molecules faster using Google Cloud's suite. Computers will take care of screening molecules and help Cerevel "get to an answer really quickly," he said.
Renger estimates Cerevel will save at least three years on average by using the suite to discover a new drug. He said it's difficult to estimate how much money the company will save, but emphasized that the suite cuts down on the resources and manual labor typically required to screen molecules.
"What it means is we can get there faster, get there cheaper and we can get to drugs to patients much more quickly without as many failures," he told CNBC.
Cerevel has been working with Google for more than a month to further understand the suite and determine how the company will use it. But Renger hopes Cerevel will "be at a place where we get some results" in the next month.
Google Clouds second solution, the Multiomics Suite, aims to help researchers tackle another daunting challenge: genomic data analysis.
Colossal Biosciences, a biotechnology company that aims to use DNA and genetic engineering to reverse extinction, has been using the Multiomics Suite in its research.
As a startup, Colossal did not have the internal infrastructure necessary to organize or decipher massive quantities of genomic data. One human genome sequence alone requires more than 200 gigabytes of storage, and researchers believe that they will need 40 exabytes to store the worlds genomic data by 2025, according to the National Human Genome Research Institute.
The institute estimates that five exabytes could store every word ever spoken by humans, so building the technology to support genomic data analysis is not a small task.
As such, the Multiomics Suite aims to provide companies like Colossal with the infrastructure they need to make sense of large amounts of data so they can spend more time focusing on new scientific discoveries.
If we had to do everything from scratch, I mean, that's the power of Google Cloud, right? Colossals vice president of strategy and computational sciences, Alexander Titus, told CNBC in an interview. We dont have to build that from scratch, so that definitely saves us time and money.
Researchers ability to sequence DNA has historically outpaced their ability to decipher and analyze it. But as technology has improved in recent years, genomic data has unlocked new insights into areas like the genetic variations associated with disease.
Google Clouds Maniar said it could ultimately aid in the development of more personalized drugs and treatments. In 2021 alone, two-thirds of drugs approved by the Food and Drug Administration were supported by human genetics research, according to a paper published in the journal Nature.
Maniar believes the Multiomics Suite will help encourage further innovation.
Ben Lamm, CEO of Colossal, said the Multiomics Suite is the reason the company has been able to carry out research on any reasonable timeline. Colossal started piloting Google's technology late last year, and as a result, Lamm said the company is on target to produce a woolly mammoth by 2028.
Without the Multiomics Suite, Lamm said he thinks the company would have been set back by over a decade.
We would not be anywhere near where we are today, he said.
Prior to using Google Clouds suite, much of Colossals data management was done manually using spreadsheets, Lamm said.
He said it would have been a massive burden on the company to try to build the more complex tools it needed for research.
We're no longer in small data when it comes to biology, said Colossals Titus. We're thinking on the scale of how do we get insights into 10,000, 20,000, 10 million years of evolutionary history? And those questions just aren't answered without scalable computing infrastructure and tools like cloud computing and Multiomics.
Correction: Scientists can take around 12 months just to identify a biological target, according to a widely followed guidance manual for drugmakers posted in a database run by the federal National Library of Medicine. An earlier version misstated the attribution.
Excerpt from:
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine - CNBC
- Commentary: Campaigns spent millions on AI in election advertising but was it effective? - Times of San Diego - November 21st, 2026 [November 21st, 2026]
- Goldman Sachs admits the 'AI unwind' has spiraled into something more dangerous and it's watching for 3 signs of bottom - Fortune - November 21st, 2026 [November 21st, 2026]
- Nations at UN talks on AI killer robots agree to more talks but no firm commitment to rein them in - NPR - November 21st, 2026 [November 21st, 2026]
- I was shaking, crying, having trouble breathing: the uncharted trauma of breaking up with AI companions - The Guardian - November 21st, 2026 [November 21st, 2026]
- The doom of humanity: will the quest to make robotic hands render us obsolete? | AI (artificial intelligence) - The Guardian - November 21st, 2026 [November 21st, 2026]
- Here are the top AI agents that can live in your text messages - TechCrunch - November 21st, 2026 [November 21st, 2026]
- Column | Before you use AI to hunt Black Friday deals, keep 5 things in mind - The Washington Post - November 21st, 2026 [November 21st, 2026]
- The AI bust is a growing threat to China's economy and a 'moment of real danger' for President Xi Jinping, analyst warns - Fortune - November 21st, 2026 [November 21st, 2026]
- The AI Skills Gap Is Becoming A Crisis Of Workforce Confidence - Forbes - November 21st, 2026 [November 21st, 2026]
- Attackers' AI Agents Found a Zero-Day in Medical-Imaging Software and Gained Root Access - The Hacker News - November 21st, 2026 [November 21st, 2026]
- Sovereign AI factory in Germany wins startups with no lock-in - SiliconANGLE - November 21st, 2026 [November 21st, 2026]
- AI may have solved the most important problem in mathematics - The Economist - November 21st, 2026 [November 21st, 2026]
- Is selling an AI version of your face to this microdrama startup the future of Hollywood? - TechCrunch - November 21st, 2026 [November 21st, 2026]
- 'This seems like an extreme privacy violation.' Surprising messages from the Muse AI agent are unnerving Meta's own employees, report says - Fortune - November 21st, 2026 [November 21st, 2026]
- "In the future, everyone's a builder." The massive AI experiment playing out in video games - Axios - November 21st, 2026 [November 21st, 2026]
- Using AI, mathematician claims to have solved one of maths great mysteries - The Washington Post - November 21st, 2026 [November 21st, 2026]
- Google told schools to accept AI or lose Search. Now 3 of Americas 4 largest districts are pushing back - Fortune - November 21st, 2026 [November 21st, 2026]
- Signal Blocks AI Agents From Reading Private Chats via Screenshots on Android and iOS - The Hacker News - November 21st, 2026 [November 21st, 2026]
- "Psychologically, it is a mountain to climb." How AI fixes the fear of fundraising. - Axios - November 21st, 2026 [November 21st, 2026]
- CrowdStrikes Talks with Zscaler Show AI-Led Cyber Consolidation - Bloomberg.com - November 21st, 2026 [November 21st, 2026]
- Can teams of AI agents recreate the chain reaction of human decisions? - Tech Xplore - November 21st, 2026 [November 21st, 2026]
- Apple may be developing its own AI agent that runs your Mac - TechCrunch - November 21st, 2026 [November 21st, 2026]
- Even the fastest AI clusters can be held back by their release pipelines - VentureBeat - November 21st, 2026 [November 21st, 2026]
- If AI Chips Become Commoditized, Nvidia Has the Most to Lose, While These 3 Stocks Are Set to Gain - The Motley Fool - November 21st, 2026 [November 21st, 2026]
- Qwen4 Max is live on Together AI - Together AI - November 21st, 2026 [November 21st, 2026]
- Anthropic researcher says he used AI to solve math's greatest riddle - DW.com - November 21st, 2026 [November 21st, 2026]
- Im opening the cage of a monster: Taxi Driver scriptwriter Paul Schrader on unleashing AI at 80 - The Guardian - November 21st, 2026 [November 21st, 2026]
- Dynatrace just laid out its AI observability playbook at KubeCon. Heres why it matters for developers. - The New Stack - November 21st, 2026 [November 21st, 2026]
- Anthropic worker claims to have solved a Holy Grail of math problems with the help of AI - AP News - November 21st, 2026 [November 21st, 2026]
- AI may eliminate jobs, but todays children can still thrive in an uncertain future - CNN - November 21st, 2026 [November 21st, 2026]
- Taco Bell Put AI in 900 Drive-Thrus Heres What Happened to Sales - Entrepreneur - November 10th, 2026 [November 10th, 2026]
- Oura to acquire AI-native primary care startup Counsel Health for $625M - TechCrunch - November 10th, 2026 [November 10th, 2026]
- The AI Race is Putting Patients at Risk - Progressive.org - November 10th, 2026 [November 10th, 2026]
- Gilbert + Tobin rethinks the business of law with AI - OpenAI - November 10th, 2026 [November 10th, 2026]
- AI Has Entered the Boardroom. Whos Overseeing It? - Stanford Graduate School of Business - November 10th, 2026 [November 10th, 2026]
- AI training startup Mercor valued at $20 billion in latest funding round - Reuters - November 10th, 2026 [November 10th, 2026]
- AI is making it harder to detect fake emergency calls - NPR - November 10th, 2026 [November 10th, 2026]
- Helping caregivers use AI in everyday life - OpenAI - November 10th, 2026 [November 10th, 2026]
- Ohio State and Microsoft announced a five-year partnership, expanding AI use in health care - The Lantern - November 10th, 2026 [November 10th, 2026]
- Nvidia CEO Jensen Huang might hang on as CEO. But his influence on U.S. AI policy is over - Fortune - November 10th, 2026 [November 10th, 2026]
- The Honeypot That Might End the AI Boom - The American Prospect - November 10th, 2026 [November 10th, 2026]
- US and China should stay clear-eyed on AI cooperation and competition, Bessent says - Reuters - November 10th, 2026 [November 10th, 2026]
- AI agents are here to help with your online shopping (where they're allowed) - Marketplace.org - November 10th, 2026 [November 10th, 2026]
- Adobe brings AI agents and new creative tools to Photoshop, Premiere, and Firefly - TechCrunch - November 10th, 2026 [November 10th, 2026]
- Spotifys AI DJ gets new voices, personalities, and an option for less chatter - TechCrunch - November 10th, 2026 [November 10th, 2026]
- CoreWeave beats on revenue and lifts guidance, easing AI slowdown concerns - CNBC - November 10th, 2026 [November 10th, 2026]
- Company says engineer stole secrets, asked AI how to get away with it - Reuters - November 10th, 2026 [November 10th, 2026]
- A single AI model simulates the behavior of many substances, from sliding sand to folding proteins - MIT News - November 10th, 2026 [November 10th, 2026]
- OpenAI, Anthropic face new oversight as New Yorks AI safety law takes effect - TechCrunch - November 10th, 2026 [November 10th, 2026]
- AI is becoming an information gateway. Audiences still dont want it making their news. - Nieman Journalism Lab - November 10th, 2026 [November 10th, 2026]
- Bloomington, Indiana, Bans Superintelligent AI, Hoping 350 Other Cities Will Follow - Reason Magazine - November 10th, 2026 [November 10th, 2026]
- Air Force previews AI training as it prepares to deploy new tools - Federal News Network - November 10th, 2026 [November 10th, 2026]
- PSI is trying to make a business out of AI-driven scientific discovery - TechCrunch - November 10th, 2026 [November 10th, 2026]
- Oura to acquire AI virtual primary care partner Counsel Health for $625M - Fierce Healthcare - November 10th, 2026 [November 10th, 2026]
- Teaching Warriors to Think With AI: The Classroom as the First Line of Cognitive Defense - Defense.info - November 10th, 2026 [November 10th, 2026]
- Nvidia-Backed Cohere in a Fight to Secure AI Computing Power - Bloomberg.com - November 10th, 2026 [November 10th, 2026]
- To save Australias economy, Albanese must share the AI gains and budget pains - Politico - November 10th, 2026 [November 10th, 2026]
- Google broadens its AI hardware portfolio with two new specialized chips - TechCrunch - November 10th, 2026 [November 10th, 2026]
- Beyond OpenAI and Anthropic: Where iCapital sees the next wave of AI winners - CNBC - November 10th, 2026 [November 10th, 2026]
- Trust beyond face-to-face contact: AI and the future of finance - CEPR - November 10th, 2026 [November 10th, 2026]
- Pimco Offloads Billions in AI Debt Just in Time to Skirt Losses - Bloomberg.com - October 28th, 2026 [October 28th, 2026]
- As AI agents reshape the web, Google opens Gemini and Search to more apps - TechCrunch - October 28th, 2026 [October 28th, 2026]
- How teachers are remaking classrooms for the AI age - Reuters - October 28th, 2026 [October 28th, 2026]
- The New York Times is adding more AI features to its Cooking app, and users arent thrilled - Nieman Lab - October 28th, 2026 [October 28th, 2026]
- CSN lands nearly $3M federal grant to expand AI, tech training - FOX5 Vegas - October 28th, 2026 [October 28th, 2026]
- I Tested Every Major AI Agent for a Day. Heres the Best One - WIRED - October 28th, 2026 [October 28th, 2026]
- Meet the Baby Boomer whose life changed when 2 Gen Z AI founders walked into her plumbing business. She became their first COO - Fortune - October 28th, 2026 [October 28th, 2026]
- AI governance starts with your data: Building the evidence the EU AI Act and new US rules expect - IAPP - October 28th, 2026 [October 28th, 2026]
- Chromes AI-powered Autofill can now dig through your Gmail to fill out forms - TechCrunch - October 28th, 2026 [October 28th, 2026]
- F5 stock suffers worst day in more than a decade as AI spending shakes investors - GeekWire - October 28th, 2026 [October 28th, 2026]
- AI tools show promise in hospitals, but experts say integration is key - Association of Health Care Journalists - October 28th, 2026 [October 28th, 2026]
- A new physics-informed AI tool aims to predict wildfire spread in real time and assist wildfire response - Phys.org - October 28th, 2026 [October 28th, 2026]
- AI's Financial Reality Check: Are The Billions Paying Off? - Forbes - October 28th, 2026 [October 28th, 2026]
- How federal agencies are adapting to AI hardware acceleration - FedScoop - October 28th, 2026 [October 28th, 2026]
- OSF Keynote: Human Connection in AI Health Care - OSF HealthCare - October 28th, 2026 [October 28th, 2026]
- Your AI Rollout May Be Moving Too Fast for Employees. It Could Cost You $25.5 Million - Inc.com - October 28th, 2026 [October 28th, 2026]
- AI Boom Drives a Jump in Lending, but Bankers Still Sound Cautious - WSJ - October 28th, 2026 [October 28th, 2026]
- New York adopts law restricting harmful AI chatbot features that target children - Syracuse.com - October 28th, 2026 [October 28th, 2026]
- AI filters may be screening out your resume. Heres how to help. - Mirror Indy - October 28th, 2026 [October 28th, 2026]
- In China, the AI bubble has already burst - Reuters - October 28th, 2026 [October 28th, 2026]